BRAINSTORM CELL THERAPEUTICS INC. 4
4 · BRAINSTORM CELL THERAPEUTICS INC. · Filed Aug 31, 2015
Insider Transaction Report
Form 4
ARBEL IRIT
Director
Transactions
- Award
Stock Option (right to buy)
2015-08-27+25,333→ 25,333 totalExercise: $0.75From: 2015-09-27Exp: 2025-08-27→ Common Stock (25,333 underlying)
Footnotes (1)
- [F1]Option vests and becomes exercisable in 12 consecutive, equal monthly installments commencing on September 27, 2015 until fully vested and exercisable on August 27, 2016, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date.